Skip to main content
Since its inception in 1998, the RBM Partnership has played a critical role in global efforts that reduced malaria deaths by half and saved 10.6 million lives. The Partnership is now committed to building on these significant gains and ending malaria for good.

During this time, the world has seen unprecedented progress in relation to malaria: the disease burden and transmission, global health architecture, international environment and leadership — notably by malaria-affected countries — have all changed considerably.

We are seeing more countries heading towards elimination. The European Region remains malaria-free. A number of African countries have achieved impressive improvements in diagnostic testing and surveillance.

  • In 2020, 65% of households in sub-Saharan Africa had at least one ITN, increasing from about 5% in 2000.

  • From 2000 to 2020, the number of countries with fewer than 100 indigenous cases increased from 6 to 26, which means elimination is within reach.

  • Innovations have accelerated in recent years – including new vaccines, treatments and rapid diagnostic tests, and ways to counter insecticide resistance.

  • Since 2000, 13 countries have been certified malaria free (Algeria, Argentina, Armenia, China, El Salvador, Kyrgyzstan, Maldives, Morocco, Paraguay, Sri Lanka, Turkmenistan, United Arab Emirates and Uzbekistan). 

RBM, founded in 1998, has never treated a patient; nor has it delivered a single bed net or can of insecticide. Rather, RBM has worked across the field of malaria eradication by helping to build public awareness, aggregate and share technical information with a system of global stakeholders, and mobilize funding.” -- Source: Stanford Social Innovation Review, January 2018